Loading...

739. Prediction of Cefiderocol Pharmacokinetics and Probability of Target Attainment in Pediatric Subjects for Proposing Dose Regimens

BACKGROUND: Cefiderocol is a siderophore cephalosporin discovered by Shionogi & Co., Ltd., which exhibits potent efficacy against Gram-negative carbapenem-resistant bacteria. Pediatric clinical studies are planned. Cefiderocol is mainly renally eliminated. A 2-g infusion of cefiderocol over 3 ho...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Katsube, Takayuki, Echols, Roger, Wajima, Toshihiro
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811267/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.807
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!